More patients and providers are aware of CT dose in 2015 than they were in 2004.
Both patients and providers seem to be more aware of CT radiation doses now than they were a decade ago, according to a study published in Emergency Radiology.
Researchers from North Carolina, Connecticut, and Washington sought to assess the patient and provider knowledge regarding CT radiation doses in 2015, compared with a study performed in 2004.
Over a two-week period, 101 patients who presented to the emergency department with mild to moderate pain requiring an abdominopelvic CT scan were surveyed. Questions included if anyone had discussed the risks/benefits of the CT scan including radiation dose and the patients were asked to estimate their dose compared to a chest X-ray. A total of 570 emergency providers, and 161 radiologists were given a similar survey, and they were also asked about potential obstacles to discussing CT radiation with patients.
Fewer than 50% of all groups could correctly select the radiation dose range of an abdominopelvic CT:
Seventy-eight percent (441/567) of emergency providers reported routinely discussing radiation dose with patients, while 20% (20/98) of patients reported that their emergency provider discussed radiation dose with them. Time limitation and concern of dissuading the patient from CT were the most commonly reported obstacles for discussing risks.
The researchers concluded while both patients and providers are now more aware of radiation doses from CT than they were in 2004, discussion regarding risks is still not commonly done.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.